Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1 Breast 1

Conditions

Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Trastuzumab 25 Carboplatin 20 Paclitaxel 19 pertuzumab 18 pyrotinib 17 Cyclophosphamide 17 Capecitabine 16 trastuzumab deruxtecan 15 Docetaxel 15 Radiotherapy 13 Standard of Care 12 Fulvestrant 12 Drug Therapy 12 dalpiciclib 11 Letrozole 11 pembrolizumab 9 Epirubicin 9 sacituzumab govitecan 8 palbociclib 8 exemestane 8 eribulin 8 Anastrozole 8 Injections 7 Doxorubicin 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 abemaciclib 6 Tamoxifen 6 Specimen Handling 6 Neoadjuvant Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Rosuvastatin Calcium × Breast × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡